BNGO vs. PFE
Compare and contrast key facts about Bionano Genomics, Inc. (BNGO) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BNGO or PFE.
Key characteristics
| BNGO | PFE | |
|---|---|---|
| YTD Return | -47.28% | -0.72% |
| 1Y Return | -86.27% | -23.07% |
| 3Y Return (Ann) | -73.73% | -7.45% |
| 5Y Return (Ann) | -52.01% | -2.43% |
| Sharpe Ratio | -1.06 | -0.91 |
| Daily Std Dev | 79.89% | 24.70% |
| Max Drawdown | -99.52% | -69.36% |
| Current Drawdown | -99.36% | -49.63% |
Fundamentals
| BNGO | PFE | |
|---|---|---|
| Market Cap | $58.17M | $157.48B |
| EPS | -$6.81 | -$0.05 |
| Revenue (TTM) | $36.12M | $54.89B |
| Gross Profit (TTM) | $5.95M | $66.23B |
| EBITDA (TTM) | -$125.72M | $9.24B |
Correlation
The correlation between BNGO and PFE is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BNGO vs. PFE - Performance Comparison
In the year-to-date period, BNGO achieves a -47.28% return, which is significantly lower than PFE's -0.72% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BNGO vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bionano Genomics, Inc. (BNGO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BNGO vs. PFE - Dividend Comparison
BNGO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 5.86%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BNGO Bionano Genomics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 5.86% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.47% | 3.34% | 3.14% |
Drawdowns
BNGO vs. PFE - Drawdown Comparison
The maximum BNGO drawdown since its inception was -99.52%, which is greater than PFE's maximum drawdown of -69.36%. Use the drawdown chart below to compare losses from any high point for BNGO and PFE. For additional features, visit the drawdowns tool.
Volatility
BNGO vs. PFE - Volatility Comparison
Bionano Genomics, Inc. (BNGO) has a higher volatility of 22.46% compared to Pfizer Inc. (PFE) at 8.64%. This indicates that BNGO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BNGO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Bionano Genomics, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities